Belgian scientists have uncovered new details about how the immune system responds to vaccines. Dendritic cells, which are ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

Yale researchers have developed a new and safe family of RNA-editing tools that utilize an RNA-targeting activity that they ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

Cemdisiran helped control symptoms of generalized myasthenia gravis, but combination treatment with a Regeneron antibody didn ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not without risk. When this type of "genetic surgery" is performed on DNA, for ...

RNA editing is positioned to be a breakthrough modality for multiple medicines. “We are incorporating proven components from other modalities for mechanism of action, administration ...

The FDA granted approval to donidalorsen for adults and children aged at least 12 years to prevent hereditary angioedema ...

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...